The percentage of patients with an ALK rearrangement varies from 1% to 5% depending on the population, and if all the histological types of NSCLC are taken into consideration or not for evaluation of the presence of an ALK rearrangement, while disregarding the smoking status [11,31,32,33,34]. The gene discussed is ALK; the disease is non-small cell lung carcinoma.